| Events
Column |
|
| 2/9
6:00 am. Deadline for registration/application/executive
summary for Yale Entrepreneurial Society Y50K Competition. more |
|
| 2/11
6:30 pm - 9:00 pm. LES CT Chapter Meeting with P. C.
Strassburger, JD of Purdue Pharma. "How Purdue
Reclaimed Its Patents from the Judicial Jaws of
Defeat." President's Room, 2nd Floor, Woolsey Hall,
Yale University, New Haven. more |
|
| 3/5
3:30 pm - 6:30 pm. CURE/Yale BioHaven: Carigent
Therapeutics, Inc. Anlyan Center, 300 Cedar Street, New
Haven. more |
|
| 3/23
1:00 pm - 7:00 pm. StemCONN 09 International Stem Cell
Symposium. Omni New Haven Hotel at Yale, 155 Temple Street,
New Haven. more |
|
| 3/24
8:30 am - 5:30 pm. StemCONN 09 International Stem Cell
Symposium. Omni New Haven Hotel at Yale, 155 Temple Street,
New Haven. more |
|
| 3/25
3:30 pm - 6:30 pm. CURE/Yale BioHaven: CellDesign. Anlyan
Center, 300 Cedar Street, New Haven. more |
|
| 3/30
6:00 pm - 8:30 pm. YBPS Presents "The Business of
Biotechnology 2009" with Constance McKee. Week-long
seminar. Yale School of Management, 135 Prospect Street, New
Haven. more |
|
| 3/30
6:00 pm - 8:30 pm. YBPS Presents "The Business of
Biotechnology 2009" with Constance McKee. Week-long
seminar. Yale School of Management, 135 Prospect Street, New
Haven. more |
|
| 3/31
6:00 pm - 8:30 pm. YBPS Presents "The Business of
Biotechnology 2009" with Constance McKee. Week-long
seminar. Yale School of Management, 135 Prospect Street, New
Haven. more |
|
| 4/1
6:00 pm - 8:30 pm. YBPS Presents "The Business of
Biotechnology 2009" with Constance McKee. Week-long
seminar. Yale School of Management, 135 Prospect Street, New
Haven. more |
|
| 4/2
6:00 pm - 8:30 pm. YBPS Presents "The Business of
Biotechnology 2009" with Constance McKee. Week-long
seminar. Yale School of Management, 135 Prospect Street, New
Haven. more |
|
| 4/23
3:30 pm - 6:30 pm. CURE/Yale BioHaven: Cara Therapeutics.
Anlyan Center, 300 Cedar Street, New Haven. more |
|
| 5/1
9:00 am - 8:30 pm. Pitch presentations begin at Yale
Entrepreneurial Society Y50K Competition. more |
|
| 5/6
3:30 pm - 6:30 pm. CURE/Yale BioHaven: Affomix. Anlyan
Center, 300 Cedar Street, New Haven. more |
|
|
|
Read
On – Powerful Reasons for Optimism
From
the desk of Paul Pescatello, President and CEO of CURE
It would have been nice if the panic of 2008 was just that, an artifact of a year gone by, but alas it has segued into 2009.
Fear not, though. Out of all the macroeconomic upheaval and upended business models there are some powerful reasons for optimism.
A more prosperous era may be on hold, but only for awhile.
For
the full story |
|
Global
Health & The Arts Symposium at Long
Wharf
New
Haven's Long Wharf Theater, in collaboration with
Yale University and CURE, hosted a unique Global
Health and The Arts Symposium January 22 designed to
focus attention on diseases of the developing world.
For
the full story |
|
CURE
Member Profile
Cheminpharma Focus Is Drug Discovery Services
Cheminpharma
is a drug discovery services company formed by two former
Bayer scientists. It provides various chemistry-based services for preclinical
drug discovery to both biotechnology and pharmaceutical
companies using their state-of-the-art facility.
For
the full story |
|
CURE
Holiday Party Draws Capacity Crowd
A
capacity crowd showed up December 3 for the CURE
Holiday Party in Café George at 300 George Street,
New Haven. Greeting the guests were CURE Co-Chairs
Peter Farina and David Keiser and CURE president and CEO
Paul Pescatello. WinStanley Enterprises was lead sponsor and
CURE member Ricerca
sponsored the DNA Game.
For
the full story |
|
CURE/Yale
Panel Tackles 'Unexpected Outcomes'
Three
seasoned life science entrepreneurs joined together in a
special panel presentation at Yale's Anlyan Center November
13 to discuss the unexpected challenges that inevitably
develop for start-up life science companies. The
presentation was part of the CURE/Yale BioHaven series of
entrepreneurship seminars.
For
the full story |
|
CURE
Holds Seminars on Drug Discovery/Approval
A series of three seminars on working with the FDA took place October 22 and 29 and November 4 at the Yale Anlyan Center in New Haven.
Presented by CURE and the Yale Biotechnology & Pharmaceutical Society, the series was sponsored by CURE, Bristol-Myers Squibb, and Rib-X Pharmaceuticals, with the participation of Achillion Pharmaceuticals, Pfizer, the U.S. Food and Drug Administration, and the law firm of Wilson Sonsini Goodrich &
Rosati.
For
the full story |
|
CURE
Member News Digest
 454
Life Sciences aids
sequencing of human gut microbiome
Achillion comments
on pipeline, foresees
compounds in the clinic
Alexion
reports Soliris® advances
Bayer
announces multiple sclerosis results
Boehringer
Ingelheim reports PRESIDE results
Bristol-Myers
Squibb announces IXEMPRA™ results
Cantor
Colburn adds intellectual property attorneys
Connecticut
Innovations
makes investmnet in FMP Products
Curagen announces
CR011-vcMMAE
trial data
Genomas
in Puerto Rican
partnership
GlaxoSmithKline
reports TYKERB®
results
Invitrogen
changes name to Life Technologies
Ipsogen
announces commercial launch of ProfileQuant®
Kit
Dr.
Stuart Lieblich of Hartford
Hospital honored
Invitrogen changes
name to Life Technologies after merger
Ipsogen
expands range of leukemia products
Johnson
& Johnson reports Phase 3 data on
schizophrenia drug
Life
Technologies SOLiD™ System hailed as
innovation
MannKind says
Phase 3 endpoints met for AFRESA™
Neurogen sees
Aplindore efficacy
Nanoviricides in
pact with Armed Forces Institute of Pathology
Pfizer
and
Sigma-Tau to market malaria drug in Africa
PhRMA
cites
effectiveness of direct-to-consumer ads
Purdue
Pharma in alliance with Mundipharma
Quinnipiac
University reports New Guinea findings
Rib-X reports
positive Phase 2 results on delafloxacin
UConn
team assesses beta blockers
Yale
reports man-made anti-clotting protein
For
the full story |
|
